Western blot analysis of Human liver cancer tissue, using SLC22A3 Polyclonal Antibody at dilution of 1:600.
SLC22A3 / OCT3 Antibody
Primary AntibodyLSBio Guarantee
| Antibody: | Rabbit Polyclonal |
| Applications: | Enzyme-Linked Immunosorbent Assay, Immunohistochemistry (general), Western Blot |
| Reactivity: | Human, Mouse, Rat |
| Format: | Liquid |
$260.00each
Catalog Number: LS-C406026-20
Catalog Number: LS-C406026
For bulk orders or custom formulations:
Request a QuoteOverview
- Description
- OCT3 antibody LS-C406026 is an unconjugated rabbit polyclonal antibody to OCT3 (SLC22A3) from human. It is reactive with human, mouse and rat. Validated for ELISA, IHC and WB. Cited in 1 publication.
- Application
- ELISA, IHC, WB
- Reactivity
- Hu, Ms, Rt
- Intended Use
- Research Use Only
- Guarantees
- This antibody carries the LSBio 100% Guarantee. ✓
- Category
- Antibodies > Primary Antibodies > Polyclonal Antibodies
- Alternative Names
- EMTH | OCT3 | Organic cation transporter 3 | EMT | SLC22A3
- Recommended Dilution: IHC
- 1:25 - 1:100
- Recommended Dilution: WB
- 1:500 - 1:2000
- UniProt Number
- O75751
- NCBI GenBank
- NM_021977 | NP_068812.1
- SwissProt
- O75751
Target
- Target
- Human SLC22A3 / OCT3
- Antigen Species
- Human
- Epitope
- Human SLC22A3 / OCT3
- Gene Name
- SLC22A3
Antibody
- Host Species
- Rabbit
- Clonality
- Polyclonal
- Isotype
- IgG
Immunogen
- Immunogen
- Synthetic peptide of human SLC22A3
- Immunogen Type
- Synthetic Peptide (Linear)
Format
- Conjugate/Label
- Unconjugated
- Format
- Liquid
- Formulation
- PBS, pH 7.4, 0.05% Sodium Azide, 50% Glycerol
- Concentration
- 0.4 mg/mL
- Volume
- 20 Microliter
- Preservative
- Yes
- Purification Method
- Affinity Purified
Storage & Handling
- Storage Conditions
- Store at -20°C. Avoid freeze-thaw cycles.
- Recommended Storage Buffer
- PBS
The Role of NF-kB in the Downregulation of Organic Cation Transporter 2 Expression and Renal Cation Secretion in Kidney Disease. Chao Han, Juan Zheng, Fengyi Wang, Qingyang Lu, Qingfa Chen, Ankang Hu, Michele Visentin, Gerd A Kullak-Ublick, Zhibo Gai, Lei Chu. Frontiers in medicine. 2022 January;8:800421. PubMed: 35059420 PMC: PMC8763702